1-5 of 5
M. HAYAT
Close
Sort by
Journal Articles

Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?

PY Dietrich, M Henry-Amar, JM Cosset, S Bodis, J Bosq, M Hayat
Journal: Blood
Blood (1994) 84 (4): 1209–1215.
https://doi.org/10.1182/blood.V84.4.1209.1209
Published: 1994
Journal Articles

Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial

NC Gorin, B Coiffier, M Hayat, L Fouillard, M Kuentz, M Flesch, P Colombat, P Boivin, S Slavin, T Philip
Journal: Blood
Blood (1992) 80 (5): 1149–1157.
https://doi.org/10.1182/blood.V80.5.1149.1149
Published: 1992
Journal Articles

Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group

R Zittoun, U Jehn, D Fiere, C Haanen, B Lowenberg, R Willemze, J Abels, J Bury, M Peetermans, M Hayat
Journal: Blood
Blood (1989) 73 (4): 896–906.
https://doi.org/10.1182/blood.V73.4.896.896
Published: 1989
Journal Articles

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

M Tubiana, M Henry-Amar, P Carde, JM Burgers, M Hayat, E Van der Schueren, EM Noordijk, A Tanguy, JH Meerwaldt, J Thomas
Journal: Blood
Blood (1989) 73 (1): 47–56.
https://doi.org/10.1182/blood.V73.1.47.47
Published: 1989
Journal Articles

A Study of Hematological Complications Occurring in Patients with Polycythemia Vera Treated with 32 P (Based on a series of 296 patients)

M. TUBIANA, M.D., R. FLAMANT, M.D., E. ATTIE, M.D., M. HAYAT, M.D.
Journal: Blood
Blood (1968) 32 (4): 536–548.
https://doi.org/10.1182/blood.V32.4.536.536
Published: 1968